Cigarette Smoking Clinical Trial
Official title:
Nicotine Regulation/Response to Low Yield Cigarettes in African-Americans vs. Whites
The investigators' general hypothesis is that African-Americans (AAs) smoke more for
positive reinforcement from nicotine with a "peak-seeking" pattern of smoking (smoking
individual cigarettes more intensively with greater intake of nicotine and tobacco smoke
toxins), while whites smoke more for negative reinforcement with a "trough-maintaining"
pattern (avoiding withdrawal by maintaining more consistent nicotine levels throughout the
day by means of a more regular smoking pattern). We, the investigators, believe that these
patterns are linked to identifiable racial differences in nicotine pharmacology.
For this study we hypothesize that if AAs behave more like nicotine "peak-seeker" while
whites behave more like nicotine "trough-maintainers", that AAs will respond to switching
from regular to low nicotine yield commercial cigarettes by smoking each cigarette
relatively more intensively with a relatively smaller increase in daily cigarette
consumption (cigarettes per day or CPD) as compared to whites.
Several lines of evidence indicate that AAs are more highly addicted to cigarette smoking
than are whites. AAs are more likely to smoke their first cigarette within 10 minutes of
awakening, an indicator of the severity of the dependence. They are more likely to want to
quit smoking and are more likely to try to quit (attempts lasting at least 24 hours, but are
significantly less likely than whites to be successful abstainers at one year. The quit
ratio (former smokers/ever smokers) was recently reported to be 37.3% in AAs compared to 51%
for whites (2).
NICOTINE REGULATION IN AAS AND WHITES: In general smokers regulate (titrate) their smoking
to take in about the same amount of nicotine from day to day. This behavior is well
demonstrated in studies of smokers smoking commercial cigarettes of differing yields,
showing that smokers take in similar amounts of nicotine from high- and low-yield
cigarettes. NCI MONOGRAPH 13 summarized the data on nicotine and low yield cigarettes and
concluded that low yield cigarettes presented the same health risks as high yield cigarettes
(12). However, most or all of the research on nicotine titration appears to have been done
primarily in white smokers.
We believe that nicotine titration patterns will differ in AAs compared to whites, based on
the hypothesis that AAs smoke more for the positive reinforcing effects of individual
cigarettes, while whites smoke more to maintain a consistent level of nicotine. We predict
that the response to switching from regular to low yield cigarettes in AAs will differ in
that they will try to take in more nicotine per cigarette by smoking more intensively, but
will be less likely to try to regulate their total daily intake of nicotine compared to
whites.
Melanin: A recent study (14) showed that levels of facultative melanin (includes both
genetically and exposure influenced melanin) in the skin are significantly and positively
related to cigarettes per day, the Fagerstrom score, and cotinine levels. By measuring
melanin levels in our own study subjects, we will be able to determine if there is a
relationship between melanin levels and nicotine pharmacokinetics.
This is a non-randomized, non-blinded, two treatment arm crossover study with an oral
nicotine and cotinine pharmacokinetic study. Cigarettes will be supplied for both treatment
arms and subjects will smoke ad libitum. During the first arm, the subject will smoke their
"usual" cigarettes and also undergo an oral pharmacokinetics protocol. During the second
arm, subjects will smoke a commercial cigarette with a machine-determined nicotine yield of
approximately 50% of their "usual" brand.
Blood and urine samples will be collected throughout the study and analyzed by our usual
methods.
;
Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Active, not recruiting |
NCT02643914 -
Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings
|
N/A | |
Recruiting |
NCT02422914 -
Benefits of Tobacco Free Cigarette
|
N/A | |
Active, not recruiting |
NCT02629679 -
Sports, Education and Consumption of Substances in Adolescents
|
N/A | |
Completed |
NCT02385227 -
Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes
|
N/A | |
Completed |
NCT02218281 -
Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation
|
N/A | |
Completed |
NCT01199380 -
Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms
|
Phase 2 | |
Completed |
NCT01692353 -
Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers
|
N/A | |
Completed |
NCT00802919 -
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
|
Phase 4 | |
Completed |
NCT01081119 -
Brief Voluntary Alcohol and Drug Intervention for Middle School Youth
|
Phase 2 | |
Completed |
NCT00756704 -
The Effectiveness of Smoking Cessation Guidelines in the Emergency Department
|
N/A | |
Completed |
NCT00682474 -
School Nurse-Delivered Smoking Cessation Intervention
|
Phase 2/Phase 3 | |
Completed |
NCT05520775 -
Semaglutide for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT03743532 -
E-Cigarettes and Financial Incentives to Promote Tobacco Harm Reduction Among Adults Accessing Shelter Services
|
N/A | |
Terminated |
NCT03840694 -
Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior
|
N/A | |
Completed |
NCT06032793 -
Effects of Deep Breathing Exercise on Pulmonary Function, Perceived Stress and Physical Fitness.
|
N/A | |
Terminated |
NCT03326128 -
High Dose Bupropion for Smoking Cessation - Pilot Study
|
Phase 2 | |
Recruiting |
NCT03218670 -
Your Health in On Click
|
N/A | |
Completed |
NCT02538042 -
Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)
|
N/A |